tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market

Intellia Therapeutics (NTLA) Income Statement

Compare
3,410 Followers

Intellia Therapeutics Income Statement

Last quarter (Q4 2024), Intellia Therapeutics's total revenue was $12.87M, a decrease of -771.57% from the same quarter last year. In Q4, Intellia Therapeutics's net income was $-128.90M. See Intellia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 57.88M$ 36.27M$ 52.12M$ 33.05M$ 57.99M
Gross Profit
$ 57.88M$ 27.30M$ 44.55M$ 26.16M$ -92.41M
Operating Expenses
$ 592.14M$ 551.57M$ 510.29M$ 300.90M$ 194.58M
Depreciation and Amortization
$ 10.29M$ 8.98M$ 7.57M$ 6.89M$ 6.31M
EBITDA
$ -523.98M$ -506.31M$ -450.59M$ -260.96M$ -130.27M
Operating Income
$ -534.26M$ -515.29M$ -458.16M$ -267.85M$ -136.58M
Other Income/Expenses
$ 15.24M$ 34.10M$ -16.02M$ -42.00K$ 2.35M
Pretax Income
$ -519.02M$ -481.19M$ -474.19M$ -267.89M$ -134.23M
Net Income
$ -519.02M$ -481.19M$ -490.21M$ -259.72M$ -125.57M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.25$ -5.42$ -6.37$ -3.66$ -2.24
Diluted EPS
$ -5.25$ -5.42$ -6.37$ -3.66$ -2.24
Weighted Average Shares Outstanding
98.85M 88.77M 76.97M 70.89M 55.99M
Weighted Average Shares Outstanding (Diluted)
98.85M 88.77M 76.97M 70.89M 55.99M
Currency in USD

Intellia Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis